Skip to main content
Back
COR logo

Cencora, Inc.

Data quality: 100%
COR
NYSE Healthcare Medical - Distribution
$320.61
▼ $6.30 (-1.93%)
Mkt Cap: 62.37B
Day Range
$320.22 $331.27
52-Week Range
$265.59 $377.54
Volume
948,549
50D / 200D Avg
$354.06 / $324.91
Prev Close
$326.91

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (626 peers)

Metric Stock Sector Median
P/E 40.1 0.4
P/B 41.4 2.9
ROE % 144.3 3.8
Net Margin % 0.5 3.9
Rev Growth 5Y % 10.7 10.0
D/E 7.1 0.2

Key Takeaways

Revenue grew 10.70% annually over 5 years — strong growth
ROE of 144.31% indicates high profitability
Debt/Equity of 7.13 — high leverage
Generating 3.21B in free cash flow
P/E of 40.13 — premium valuation
Cash machine — converts 206.36% of earnings into free cash flow

Growth

Revenue Growth (5Y)
10.70%
Revenue (1Y)9.31%
Earnings (1Y)2.99%
FCF Growth (3Y)-3.63%

Quality

Return on Equity
144.31%
ROIC22.32%
Net Margin0.48%
Op. Margin1.14%

Safety

Debt / Equity
7.13
Current Ratio0.90
Interest Coverage8.69

Valuation

P/E Ratio
40.13
P/B Ratio41.36
EV/EBITDA18.84
Dividend Yield0.01%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 9.31% Revenue Growth (3Y) 10.71%
Earnings Growth (1Y) 2.99% Earnings Growth (3Y) -5.63%
Revenue Growth (5Y) 10.70% Earnings Growth (5Y) 0.23%
Profitability
Revenue (TTM) 321.33B Net Income (TTM) 1.55B
ROE 144.31% ROA 2.03%
Gross Margin 3.16% Operating Margin 1.14%
Net Margin 0.48% Free Cash Flow (TTM) 3.21B
ROIC 22.32% FCF Growth (3Y) -3.63%
Safety
Debt / Equity 7.13 Current Ratio 0.90
Interest Coverage 8.69 Dividend Yield 0.01%
Valuation
P/E Ratio 40.13 P/B Ratio 41.36
P/S Ratio 0.19 PEG Ratio 7.05
EV/EBITDA 18.84 Dividend Yield 0.01%
Market Cap 62.37B Enterprise Value 68.72B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 321.33B 293.96B 262.17B 238.59B 213.99B
Net Income 1.55B 1.51B 1.75B 1.70B 1.54B
EPS (Diluted) 7.96 7.53 8.53 8.04 7.39
Gross Profit 10.14B 8.70B 7.76B 7.60B 6.27B
Operating Income 3.65B 3.04B 2.45B 2.75B 2.68B

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 76.59B 67.10B 62.56B 56.56B 57.34B
Total Liabilities 74.84B 66.31B 61.89B 56.49B 56.75B
Shareholders' Equity 1.51B 645.94M 522.00M -211.56M 223.35M
Total Debt 10.75B 6.65B 6.82B 7.59B 8.75B
Cash & Equivalents 4.39B 3.23B 2.69B 3.53B 2.55B
Current Assets 52.24B 47.72B 42.80B 39.59B 38.80B
Current Liabilities 57.82B 54.28B 48.83B 43.48B 41.36B

Strategy Scores

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#446 of 613
20

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026